Discover how the ALA-CART platform enhances CAR T cell efficacy against antigen-low leukemias. With improved LAT activation, ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform. The deal will see AstraZeneca scoop up all ...

A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

The agency will reject all data from the Chinese service provider’s studies after Mid-Link failed to address concerns ...

Poland: A recent simulation study published in Scientific Reports revealed that individuals with asthma and chronic ...

ARC101, a potential best-in-class T-cell engager that targets solid tumors expressing CLDN6, is being assessed in a ...

Biological tests revealed that certain triterpene saponin compounds exhibited strong activity against all five tested cancer ...

The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

DELO has released a new light-curing medical-grade adhesive engineered with nontoxicity in mind. DELO PHOTOBOND MG4047 is ...

Radiation-resistant nanomaterials enhance durability in nuclear systems by mitigating damage, improving structural integrity, ...